FDA Advisories

  • FDA Advisory No. 2014-068 || Public Health Advisory on Taiwan Food and Drug Administration's Announced Lard Oil Products Believed to be Tainted with Recycled Waste Oil

  • FDA Advisory No. 2013-053-A || Update on FDA Advisory No. 2013-053 Re: Toxic Mercury-Laden Skin Whitening Cosmetic Products Without Notification that were Tested by the FDA

  • FDA Advisory No. 2014-067 || Food and Drug Administration (FDA) and Philippine Pharmacists Association (PPhA) Mull Plan to Authorize Community Pharmacists to Administer Vaccines

  • FDA Advisory No. 2014-066 || Voluntary Recall of Specific Batches of Tetrahydrozoline HCL 0.05% Opthalmic Solution (Eye-Mo Red Eyes Formula) with Registrationn Number DRHR-431

  • FDA Advisory No. 2014-065 || Voluntary Recall of Specific Batches of NICORANDIL (APRIOR) 5 mg and 10 mg Tablets with Registration Nos. DR-XY35217 and DR-XY31195



FDA Satellite Office - Ali Mall Cubao, Quezon City

The Food and Drug Administration (FDA) Satellite Office in Ali Mall Cubao, Quezon City will start receiving applications for License to Operate (LTO), Certificate of Product Registration (CPR) and other authorizations following the Public Assistance, Information and Receiving (PAIR) procedure beginning 15 September 2014, Monday from 10am - 6pm. However, only those applications scheduled for the day with payment of appropriate fees and charges will be accepted. Applicant companies are further advised to submit product registrations for vaccines and biological at FDA Alabang.

Submission of letter request and other communication such as ADRs/AEs, Clinical Trial Protocols and other related documents will be also received following the existence procedure.

For your Information and Guidance.

Switch to Desktop Version